interferons
Type I Interferon Responses Enhance the Regenerative Activity of Salivary Gland Stem Cells After Radiotherapy
Blockade of IFN-β or RIG-I Attenuates This Effect
Antiviral Defense of the Nasal Mucosa Weakens With Age
Prolonged Infection Leads to More Severe Disease
Endogenous Retroelements as Regulators of Oral Tolerance
The cGAS–STING Pathway Is Required for Protection Against Food Allergy
Therapeutic Potential of Type I Interferon in Enhancing Sensitivity to Cancer Immunotherapy
Type I Interferon Regulates Metastasis and Improves Tumor Response to Immune Checkpoint Blockade
Long COVID: Chronic Inflammation and T Cell Dysfunction
JAK–STAT, IL-6, and Interferon Signaling Pathways as Potential Therapeutic Targets
Nasal Interferon Reduces the Period of Infectiousness in Children Infected With Coronavirus
Shortening the Period – Containing the Pandemic
Gut Microbiota as a Regulator of Innate Antiviral Immunity
Intestinal Bacteria Are Required for Basal Activation of the cGAS–STING–IFN-I Axis
Children With Severe Influenza Produce Little Interferon in the Nose
Mild Influenza Is Associated With Much Higher Interferon Levels
Autoantibodies to Interferon Alpha in Patients With Antibody Deficiency
Autoantibodies Are Rare and Do Not Affect Coronavirus Vaccination
Breastfeeding Protects Infants From Severe Influenza by Activating Type I Interferon Production
The Effect Is Observed for Influenza but Not for RSV or Metapneumovirus
Autoantibodies to Type I Interferons Increase the Risk of Fulminant Hepatitis Caused by HSV
Therapeutic Opportunities With Interferons
Autoantibodies to Type I Interferons – A Risk Factor for Fatal Avian Influenza H5N1
A Case of Pneumonia in a 71-Year-Old Man
PLD4 Mutations as a Genetic Cause of Systemic Lupus Erythematosus
PLD4 Deficiency Leads to Excessive Activation of the Type I Interferon Pathway
Nasal Interferon Restores the Nasal Immune Landscape During Viral Infection
Type I Interferon Accelerates Clearance of Metapneumovirus
Infections as a Key Factor in Prematurity and Infant Mortality
The Importance of Preventing ARVI and STIs in Reducing the Risk of Placental Pathology
Prevention of ARVI in Pregnant Women and Newborns: Evaluating the Efficacy and Safety of Intranasal Interferon
Intranasal Interferon α-2b Prevents ARVI and Mitigates Disease Severity
Type I Interferons Are Essential for Early Control of Candida albicans in Vulvovaginal Candidiasis
Absence of IFN-I Signaling Increases Fungal Burden and Inflammation
How the Immune System Responds to Tuberculosis: The Role of Type I Interferons, Neutrophils and T Cells
Early Immune Mechanisms That Determine the Outcome of Mycobacterium Tuberculosis Infection
Defects in the Type I Interferon Pathway Contribute to Immunopathology in Herpetic Encephalitis
NF-κB Blockade Reduces the Severity of Herpetic Encephalitis in Mice with the IRF3 R278Q Mutation
Ketogenic Diet During Cancer Immunotherapy Boosts Interferon Production
Survival Increases from 42% to 67%
Fumarate Enhances Interferon Production During Viral Infection
Fumarate Directly Activates MAVS – A Central Component of the Antiviral Signaling Pathway
Type I and Type III Interferons Disrupt Lung Repair After Viral Infection
Interferon-λ Impairs Lung Barrier Function via p53 Activation
mRNA IFN-I Nanoparticles Suppress Lung Metastases
A Candidate for Third-Generation Interferon-Based Cancer Therapy
NKp30 NK Cells Determine the Effectiveness of Peg-IFN-α2b Therapy in Chronic Hepatitis B
Why Interferon Therapy Is Not Effective for Everyone
How Aging Alters the Response to Coronavirus
STAT3-Dependent Processes – The Basis of Severe COVID-19 in the Elderly
Interferon-α Promotes Functional Cure of Chronic Hepatitis B by Inducing Liver Steatosis
Elevated Lipid Levels May Improve Response to Peg-IFN Therapy
SLIC-IFN-γ: Bacteria That Help Overcome Resistance to Cancer Immunotherapy
Targeted Delivery of Interferon-γ Enhances the Effect of PD-1 Blockade
Regulatory T Cells in Brown Adipose Tissue Support Thermogenesis by Suppressing Interferon-Gamma Production
Treg Protects Mitochondria and Prevents Metabolic Dysfunction
Interferon Gamma Reduces the Angiogenic Potential of Cancer Cells
IFN-γ Suppresses Perlecan Gene Expression and Tumor Growth
SPENCD: A Rare Bone Disease Identified as an Interferonopathy
ACP5 Gene Mutations Lead to Excessive Interferon Pathway Activation
Type I Interferons Increase Gonococcal Survival
Interferon-Epsilon Promotes Gonorrhea Progression
Type I Interferons and T Cell Dysregulation in IBD
Endogenous IFN-β Controls Intestinal Inflammation
Interferons in Inflammatory Bowel Disease
The Protective and Damaging Roles of Interferons and Their Therapeutic Potential
Interferon-γ and Serotonin in Irritable Bowel Syndrome
Interferon-γ Increases Serotonin Availability, Disrupting Gut Motility
The Role of Interferon in Cellular Senescence
Targeting the Interferon Signaling Pathway May Extend a Healthy Lifespan
Why Bats Carry Viruses Without Getting Sick
Interferon Lambda Suppresses Marburg Virus
Type I Interferon Reduces Monkeypox Severity
Early Administration Maximizes Antiviral Effectiveness
Interferon-Gamma Against Leptomeningeal Metastases
For Antitumor Effect, IFNγ Requires NK Cells
Β-Glucan Reprograms Immunity and Reduces Influenza Severity
Protective effect depends on type I interferon, Dectin-1, and T cells
PD-L1 Suppresses Interferon Response, Enhancing Oncolytic Virus Efficacy”
Combining oncolytic viruses with PD-1/PD-L1 blockers is a promising cancer treatment strategy
Interferon-gamma suppresses the anti-tumor activity of T cells
Ablation of IFN-γ receptor on CD8+ T cells enhances tumor control
METTL3 Inhibitor Triggers Interferon Response, Enhancing Anti-Tumor Immunity
A combination of METTL3 inhibitor and anti-PD-1 improves cancer survival
Type I Interferons Produced During Viral Infections Suppress Metastasis
RSV Infection Prevents Lung Metastasis Development
Type I Interferons Suppress Malaria at the Liver Stage
Two Mechanisms of Plasmodium Suppression in the Liver
Type I Interferons Help NK Cells Absorb Iron
Iron Enhances the Antiviral Activity of NK Cells
How Nasopharyngeal Lymphoid Tissue Responds to SARS-CoV-2 in Adults
Lymphoid Tissue Provides Coordinated Defense Against Viruses
Rapid Decline of Interferon-α2 is Associated with the Risk of Death from COVID-19
Type I Interferon Treatment May Help Severe Patients
Interferon Alpha-2b in Pulmonary Hypertension
Interferon Reduces Right Ventricular Hypertrophy
Type I and III Interferons in Asthma and Exacerbations
Respiratory Infections Trigger Asthma Exacerbations
Reactivating HIV to Eradicate It
Combination Therapy for HIV: Panobinostat and Pegylated Interferon-α2a
Protection Against Influenza: The Critical Role of Interferon-Lambda
Interferon-λ Signaling in Macrophages is Essential for Antiviral Response to Influenza
Rotavirus NSP1 Protein Suppresses Type I and III Interferon Production
NSP1 Enables Rotavirus to Evade Immune Detection
Increased Frequency of Dendritic Cells Following Antiretroviral Therapy Interruption Indicates Subclinical HIV Replication
Dendritic Cells Lose Their Ability to Produce Interferon-α
How Thymic Cells Prevent Autoimmune Reactions
Type III Interferon Increases the Capacity of Thymic Cells to Ensure CD8+ T-Cell Tolerance
Early Interferon Response Protects Against Coronavirus Infection Despite Exposure
Increased IFN-Related Gene Activity Within 6 Hours After Exposure Prevents Infection
How Gamma Interferon Contributes to the Pathogenesis of Type 1 Diabetes
JAK Inhibitors – A Novel Approach to Diabetes Treatment
Diagnosing ARVI via Interferon Levels
Nasal Interferon Levels Combined with PCR Testing Improve Diagnostic Accuracy to 94%
Lurbinectedin and Atezolizumab for Small-Cell Lung Cancer
Lurbinectedin Enhances IFN Signaling to Boost Immunotherapy Efficacy
New Frontiers in Lung Cancer Treatment: STAT3 and Interferon Therapy
The STAT3-STING-IFN Axis Governs Small-Cell Lung Cancer Metastasis
Interferons and Erythropoiesis: How the Body Prevents Anemia During Pregnancy
The Role of Retrotransposons in Maintaining Red Blood Cell Levels
Persistence of SARS-CoV-2 in Alveolar Macrophages is Regulated by IFN-γ and NK Cells
SARS-CoV-2 Exploits MHC-E to Evade the Immune Response
Iron Deficiency Suppresses Memory T-Cell Response to Influenza
Iron Deficiency Reduces Interferon-Gamma Production and Weakens Antiviral Defense
Interstitial Macrophages: Key Culprits in Severe COVID-19
The Coronavirus Exploits Interstitial Macrophages for Replication
COVID-19 Enhances Flu Response by Creating Innate Immune Memory
Coronavirus alters the genetic activity of alveolar macrophages
Impaired Tolerance of Self-Tissues Leads to Autoantibodies Against IFN-I
Autoantibodies against type I interferons (IFN-I) increase susceptibility to severe infections
How Obesity Worsens the Course of Multiple Sclerosis in Women
Interferon-α: A Key Factor in the Development of Autoimmune Diseases in Obesity
Interferon-γ Contributes to Respiratory Complications After COVID-19
Blocking IFN-γ: A New Approach to Treating Post-COVID Syndrome
How the Body Responds to Coronavirus at Different Stages of Infection
Scientists Infect Volunteers with SARS-CoV-2 to Understand the Immune System's Battle Against the Virus
Pharmacodynamics of Nasal Interferon Alpha-2b and Effective Prevention of Coronavirus Infection
Research on high-risk groups
Interferons in Cancer Immunotherapy
How Interferons Affect Immune Cells and Tumors
Genetic Roots of Severe Infections: From Coronavirus to EBV
Why Some Children Suffer More Severely
Influenza Virus Utilizes Miz1 Protein to Suppress Interferons
Influenza Boosts Miz1 Levels to Facilitate Unimpeded Replication
The Impact of Alternate-Day Fasting on Metabolism, Immunity, and Hormones
The effect depends on gender
Autoantibodies to Interferons Are Not Associated with Chronic Fatigue after COVID-19
Only 1.6% of patients with post-COVID syndrome had autoantibodies to IFN-β
Autoantibodies to Type I Interferons in COVID-19 Patients
Autoantibodies to tissues, immune cells and interferons complicate the course of COVID-19
Genetic Trick of Omicron: Evasion of the Innate Immune System
Coronavirus gene Orf6 suppresses immune responses
Macrophages Shield Against Excessive Inflammation in Respiratory Viral Infections
Macrophages produce oncostatin M and suppress the excessive interferon response
Canine Parvovirus Suppresses Innate Immunity
Interferon Treatment Restores Immune Response
Type I Interferon’s Dual Effect on Immunity
Reduced Inflammation but Increased Susceptibility to Candidiasis
Interferon for Treating Canine Parvoviral Enteritis
Effectiveness of Type I Interferon Against Parvovirus in Beagle Puppies
Interferon Alpha for Children with Chronic Hepatitis B: Long-Term Treatment Effects
Results of a 13-Year Study
Interferon Beta-1b for the Treatment of Pediatric Multiple Sclerosis
Two-Year Study Results
The Role of Commensal Bacteria in Sustaining Gut Health through Type I Interferons
Bacteroides fragilis protects against inflammation
Post-COVID Syndrome Linked to Low Serotonin Levels
Viral inflammation disrupting serotonin synthesis and accumulation
Obesity Disrupts Antiviral Response to Influenza
Adipose tissue hormone suppresses interferon production in macrophages
A Pan-Coronavirus Nasal Vaccine Developed in Hong Kong
A nasal vaccine containing interferon protects Omicron and other coronavirus strains
Interferon Alpha-2b Enhances Protection Against Omicron in Vaccinated Individuals
A Study on High-Risk Medical Workers
Progesterone Inhibits Interferon Epsilon in The Female Reproductive Tract
Hormonal contraception – possible risk of STIs
Properties and Antiviral Activity of Interferon Epsilon
IFN-ε may protect against HIV
How The Immune System Contributes to Brain Aging
cGAS-STING blockade may prevent aging-related neurodegeneration
Modified Interferon α2 Inhibits Coronavirus Replication and Inflammation
IFNmod protects against IFN-I-associated lung injury
Type I Interferons are Required to Protect Against Bacterial Pneumonia
IFN-I controls MAIT cell functions during K. pneumoniae infection
Interferon-α Inhibits Melanoma Metastasis
IFN-alpha reduces the ability of cancer stem cells to form tumors
Interferon α2b and Vitamin D Reduce Inflammation in Vaginal Infections in Pregnancy
Influence of complex therapy on the balance of cytokines
Lacidophilin Improves The Efficacy of Interferon α-2b in Treating Human Papillomavirus
Safe prevention of cervical cancer in HPV patients
Interferon Influences the Effectiveness of Radiotherapy
Radiotherapy triggers an antitumor response when it does not target healthy tissue
Efficacy and Safety of Interferon-Alpha for the Treatment of RSV Pneumonia in Infants
Symptoms resolve much faster
Interrelation between Oral Candidiasis and Diabetes Mellitus
Decreased interferon-gamma and increased IL-10 increase the risk of Candida